Lipid-lowering Effect of Plant Stanol Yogurt
Launched by RAISIO GROUP · Jun 18, 2013
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
Efficacy of plant stanols as esters on LDL-cholesterol reduction is well documented. LDL-cholesterol lowering efficacy of the ingredient administered in a yogurt is less well known.
Study was monitored by Foodfiles
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • subjects must voluntarily sign the informed consent
- • subjects must be male or female aged 20 to 70 years
- • subjects must have a serum total cholesterol concentration of 5.2 - 7.5 mmol/l ( 205 - 290 mg/dl) at the screening visit (visit 1, -2 week)
- Exclusion Criteria:
- • subjects using lipid lowering medication
- • subjects using ezetimibe
- • subjects with bile acid sequestrant medication
- • subjects with statin therapy
- • subjects using other medication significantly influencing on lipid values
- • subjects with diagnosis type 1 or type 2 diabetes
- • severe obesity (BMI\>35.0 kg/m2)
- • serum fasting triglycerides \> 4.0 mmol/l
- • subjects with any hepatic or renal disorder according to medical history
- • subjects who have history of myocardial infarction or unstable angina pectoris within six months prior to screening
- • subjects who have history of coronary artery bypass graft or percutaneous transluminal coronary angioplasty within six months prior to screening
- • subjects who have history of temporal ischemic attack or stroke within six months prior to screening
- • subjects who have a history of cancer or other malignant disease within the past five years
- • subjects with abnormal values of health screening variables measured at screening visit: serum gamma-glutamyltransferase\> 2 x upper limit, serum alkaline phosphatase\> 2 x upper limit or other abnormality in laboratory evaluations considered as clinically significant in the opinion of the study physician
- • subjects who are consuming more than 15 portions of alcohol / week
- • subjects who are pregnant or lactating
- • subjects using Benecol, Becelpro.activ, Danacol or other plant sterol enriched products within 30 days before visit 2
- • subjects with severe lactose intolerance, milk allergy or any other intolerance to the ingredients of test products
- • celiac disease
About Raisio Group
Raisio Group is a leading international company specializing in the development and production of healthy food products and functional ingredients, with a strong emphasis on sustainability and innovation. With a rich heritage in the food industry, Raisio Group is committed to enhancing consumer health through scientifically backed solutions and high-quality offerings. The company actively engages in clinical trials to validate the health benefits of its products, ensuring they meet the highest standards of safety and efficacy. Through its dedication to research and development, Raisio Group aims to contribute to the well-being of individuals while promoting responsible environmental practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials